ES8406195A1 - Procedimiento para la obtencion de 1,2,3,4-tetrahidropiridinas - Google Patents

Procedimiento para la obtencion de 1,2,3,4-tetrahidropiridinas

Info

Publication number
ES8406195A1
ES8406195A1 ES526673A ES526673A ES8406195A1 ES 8406195 A1 ES8406195 A1 ES 8406195A1 ES 526673 A ES526673 A ES 526673A ES 526673 A ES526673 A ES 526673A ES 8406195 A1 ES8406195 A1 ES 8406195A1
Authority
ES
Spain
Prior art keywords
tetrahydropyridines
preparation
antihypertensives
nitrile
heterocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES526673A
Other languages
English (en)
Other versions
ES526673A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES8406195A1 publication Critical patent/ES8406195A1/es
Publication of ES526673A0 publication Critical patent/ES526673A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE 1,2,3,4-TETRAHIDROPIRI DINAS.CONSISTE EN PREPARAR COMPUESTOS DE FORMULA (I) DONDE R SIGNIFICA ARILO, TIENILO U OTROS; R UN RESTO HIDROCARBURO SATURADO O INSATURADO DE CADENA RECTA, RAMIFICADA Y CICLICA; R Y R UN RESTO ALQUILO DE CADENA RECTA Y RAMIFICADA U OTROS; R SIGNIFICA UN HIDROGENO U OTROS, Y COMPRENDE: A) COMPUESTOS DE DIHIDROPIRIDINA DE FORMULA (II) DONDE R, R, R, R, R Y X TIENEN LOS SIGNIFICADOS ANTERIORES; B) COMPUESTOS DE PIRIDINA DE FORMULA (III) DONDE R, R, R, R Y X TIENEN LOS SIGNIFICADOS ANTERIORES. SE REDUCEN ELECTROQUIMICAMENTEEN UN CATODO EN PRESENCIA DE UN ELECTROLITO.POSEE PROPIEDADES FARMACOLOGICAS COMO ANTIHIPERTENSIVOS Y COMO VASODILATADOR PERFIERICO Y CEREBRAL.
ES526673A 1982-10-23 1983-10-21 Procedimiento para la obtencion de 1,2,3,4-tetrahidropiridinas Granted ES526673A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823239273 DE3239273A1 (de) 1982-10-23 1982-10-23 Tetrahydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln

Publications (2)

Publication Number Publication Date
ES8406195A1 true ES8406195A1 (es) 1984-07-01
ES526673A0 ES526673A0 (es) 1984-07-01

Family

ID=6176423

Family Applications (1)

Application Number Title Priority Date Filing Date
ES526673A Granted ES526673A0 (es) 1982-10-23 1983-10-21 Procedimiento para la obtencion de 1,2,3,4-tetrahidropiridinas

Country Status (7)

Country Link
US (2) US4568681A (es)
EP (1) EP0110073B1 (es)
JP (1) JPS5993048A (es)
AT (1) ATE28076T1 (es)
CA (1) CA1252470A (es)
DE (2) DE3239273A1 (es)
ES (1) ES526673A0 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4342196A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Neue 4-Phenyl-substituierte 1,4-Dihydropyridine
DE3414801A1 (de) * 1984-04-19 1985-10-24 Bayer Ag, 5090 Leverkusen 4-(nitrophenyl)-tetrahydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4678796A (en) * 1984-11-30 1987-07-07 Warner-Lambert Company 2-alkylidene derivatives of 1,2,3,4-tetrahydropyridine-2,5-pyridine carboxylic acid dialkyl esters useful for treatment of cardiovascular disorders
HUT39179A (en) * 1984-12-10 1986-08-28 Sandoz Ag Process for production of derivatives of 1,4-dihydro-piridin
FI862343A (fi) 1985-06-17 1986-12-18 Warner Lambert Co Foerfarande foer framstaellning av terapeutiskt verkande 1,4-dihydropyridinfoereningar.
US4788203A (en) * 1985-11-26 1988-11-29 Merck & Co., Inc. Cyclized N-substituted-tetrahydropyridine compounds, useful in the treatment of cardiovascular disorders
US4732898A (en) * 1986-04-29 1988-03-22 Warner-Lambert Company 2-(2-aryl-2-oxoalkylidene) analogs of-3,5-pyridinedicarboxylic acid dialkyl esters useful for treatment of cardiovascular disorders
DE3700307A1 (de) * 1987-01-08 1988-07-21 Bayer Ag Tetrahydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5337085A (en) * 1992-04-10 1994-08-09 Comsat Corporation Coding technique for high definition television signals
DE4236707A1 (de) * 1992-10-30 1994-05-05 Bayer Ag 4-Heterocyclyl substituierte Dihydropyridine
US6001857A (en) * 1992-10-30 1999-12-14 Bayer Aktiengesellschaft Heterocyclyl substituted dihydropyridines
DK0595164T3 (da) * 1992-10-30 1997-05-26 Bayer Ag 4-Heterocyclophenyl-substituerede dihydropyridiner
DE4342193A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Arylsubstituierte Alkoxycarbonyl-1,4-dihydropyridin-5-carbonsäureester
EE03192B1 (et) * 1993-12-10 1999-06-15 Bayer Aktiengesellschaft Isopropüül-(2-metoksüetüül)-4-(2-kloro-3-tsüanofenüül)-1,4-dihüdro-2,6-dimetüülpüri diin-3,5-dikarboksülaat, selle enantiomeerid ja vaheühend, meetodid nimetatud ühendite valmistamiseks ja kasutamine
ES2193148T3 (es) 1993-12-10 2003-11-01 Bayer Ag 1,4-dihidropiridinas sustituidas con fenilo con actividad cerebral.
KR20010020267A (ko) * 1997-04-25 2001-03-15 에가시라 구니오 신규한 디하이드로피리딘 유도체
US5992637A (en) * 1997-07-14 1999-11-30 Southpac Trust International, Inc. Packaging material
CA2708118A1 (en) * 2007-12-14 2009-06-25 Merck Sharp & Dohme Corp. Mineralocorticoid receptor modulators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2658804A1 (de) * 1976-12-24 1978-07-06 Bayer Ag Kreislaufbeeinflussende mittel
DE3022030A1 (de) * 1980-06-12 1981-12-17 Bayer Ag, 5090 Leverkusen 4-thiazol- bzw. 4-imidazol-substituierte, 1,4-dihydropyridine, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
GR74919B (es) * 1980-07-16 1984-07-12 Rhone Poulenc Agrochimie

Also Published As

Publication number Publication date
EP0110073B1 (de) 1987-07-01
US4559350A (en) 1985-12-17
DE3239273A1 (de) 1984-04-26
EP0110073A1 (de) 1984-06-13
JPS5993048A (ja) 1984-05-29
DE3372287D1 (en) 1987-08-06
ES526673A0 (es) 1984-07-01
US4568681A (en) 1986-02-04
ATE28076T1 (de) 1987-07-15
CA1252470A (en) 1989-04-11

Similar Documents

Publication Publication Date Title
ES8406195A1 (es) Procedimiento para la obtencion de 1,2,3,4-tetrahidropiridinas
ES8606279A1 (es) Procedimiento para la obtencion de piridonas.
ES464463A1 (es) Un procedimiento para preparar derivados de acilo sustituidode aminoacidos.
ES8609251A1 (es) Un procedimiento para preparar un compuesto de n-aril-n- -(4-piperidinil)-alcoxialquilamida
ES8802493A1 (es) Procedimiento para la obtencion de amidas de acidos benzoheterociclilalcanoicos.
ES477695A1 (es) Un procedimiento para preparar derivados de deshidrociclici-minoacidos.
BG38639A3 (en) Method for preparing ester derivatives of 6- beta- hydroxymethylpenicillanic acid
ES479410A1 (es) Un procedimiento para la preparacion de derivados del acido 4-tiazolidincarboxilico.
DE3277970D1 (en) (4-oxo-4h-(1)-benzopyran-8-yl)-alkanoic acids, salts and derivatives, preparation and medicines containing them
ES8406193A1 (es) Procedimiento para la preparacion de nuevas 1,4-dihidropiridinas sustituidas
ES469265A1 (es) Procedimiento para la fabricacion de derivados del acido omega-aminoacilamisulfonico
DE3372364D1 (en) 1-carboxyalkanoylperhydroindole-2-carboxylic acids and derivatives
ZA873721B (en) Substituted 6-hydroxymethyl-carbapenem antibiotics,a process for the preparation thereof,and the use thereof
ES8106276A1 (es) Un procedimiento para la preparacion de amidas del acido po-liprenilcarboxilico
ES8306994A1 (es) Procedimiento para la obtencion de diamidas de acido hidroxi-maloico sustituidas.
AP8800109A0 (en) "Heterocyclic insecticides".
GR79508B (es)
ES8607935A1 (es) Un procedimiento de preparar un derivado de ariltio-piridi- nil-alcanol
HUT46044A (en) Process for producing immunstimulant peptides inhibiting multiplication of leukaemic cells and pharmaceutics comprising same
ES8303434A1 (es) Procedimiento para la obtencion de amidas del ester de acido fosforico (fosfonico).
RO87991A (ro) Procedeu pentru prepararea unor esteri tiazolidinici substituiti ai unor acizi minerali
ES424204A1 (es) Un procedimiento para la preparacion del acido 6 beta-aci- lamido-1-oxadestiapenicilanico y derivados del mismo.
ES467886A1 (es) Procedimiento para la preparacion de derivados de acido oleanoico.
DE3064069D1 (en) (-)-alpha-(2-(bis(1-methylethyl)amino)ethyl)-alpha-phenyl-2-pyridineacetamide and pharmacologically acceptable salts thereof, process for the production thereof and compositions containing the same
ES8703847A1 (es) Procedimiento para la obtencion de derivados de sulfonilgua-nidinopirimidina